Brind.

Jay Lieberman claimed in 2018 that the FDA would review a treatment soon.

1 report, 1 independent Updated Sep 12

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Jay Lieberman FDA

Keep exploring

The entities involved

Jay Lieberman
basketball player

Nothing else this week.
FDA
- Political rhetoric is challenging the market approval process for vaccines by the FDA.05:59
- Regeneron, the FDA, and research institutions are advancing the Ebola response in the DRC through drug approvals and clinical trials.05:37

Related events

Adam Craig reported positive results that could support FDA approval for a treatment.Sat 05:41

Coverage

Newest first; wire copies grouped

science20.com